Shawn Cline Tomasello has over 30 years of experience in pharmaceutical and biotech industries, most recently, as the Chief Commercial Officer at Pharmacyclics where she led the commercial and medical affairs teams. Ms Tomasello has extensive strategic experience in building world class organizations. While at Pharmacyclics, the market cap increased significantly, resulting in an acquisition by AbbVie for $21 billion. Ms Tomasello is the former President of the Americas, Hematology and Oncology, for Celgene Corporation where she was responsible for all aspects of the commercial organization. Prior to joining Celgene, Ms Tomasello was at Genetech for 16 years in various roles, including, National Director of Hematology for Rituxan. Earlier in her career, she held positions at Pfizer Laboratories, Miles Pharmaceuticals and Proctor & Gamble. Ms Tomasello received her B.S. in Marketing from the University of Cincinnati and her M.B.A. from Murray State University, Kentucky. She has served on the board of BIONJ and has been a member of the advisory board for Healthcare Businesswomen’s Association (HBA).